Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2026 Aug 11;17:1880522. doi: 10.3389/fphar.2026.1880522

Bisphenol A exacerbates dry eye disease via the CASP1/GSDMD-mediated pyroptotic axis: network toxicology, mendelian randomization, and experimental validation

Yingchen Wang 1, Chenhong Jiang 2, Yu Zhang 3, Kangrui Liu 2, Kang Lu 2, Youhai Wang 2, Minglu Xu 2, Qing Wang 1,*
PMCID: PMC13503577  PMID: 42643620

Abstract

Background

Bisphenol A (BPA) is a pervasive environmental contaminant associated with various systemic toxicities. However, its specific mechanistic involvement in dry eye disease (DED) pathogenesis is not defined. This study aimed to evaluate the toxicological mechanisms of BPA in DED pathogenesis and identify the key molecular mediators driving ocular surface injury.

Methods

Toxicity profiles of BPA were predicted using the ProTox and ADMETlab platforms. Network toxicology and machine learning were used to explore pathogenic pathways and molecular mechanisms. Mendelian randomization (MR) analysis was performed to assess the causal effects of candidate targets on DED. Immune infiltration analysis and Gene Set Enrichment Analysis (GSEA) were used to characterize functional features and immune associations. Molecular docking and molecular dynamics (MD) simulations evaluated the spatial engagement and stability between BPA and the hub target. Finally, in vitro assays (CCK-8, LDH release, propidium iodide staining, ROS detection, qRT-PCR, and Western blot) using human corneal epithelial cells (HCECs) were conducted to validate the BPA-induced cytotoxicity and the molecular mechanisms.

Results

Toxicity assessments predicted significant ocular irritant and corrosive properties for BPA. Machine learning algorithms identified CASP1 as the hub gene. MR analysis provided genetic evidence that elevated CASP1 expression causally increases DED risk (OR = 1.11, 95% CI: 1.06–1.16). Molecular docking demonstrated stable binding affinity (−5.1 kcal/mol) between BPA and the CASP1 protein. 100-ns molecular dynamics simulations confirmed its structural equilibrium and spontaneous thermodynamic stability with an MM-PBSA binding free energy of −12.19 kcal/mol. In vitro, BPA exposure decreased HCEC viability, compromised membrane integrity, and triggered significant intracellular ROS accumulation. BPA significantly upregulated the mRNA and protein expression of caspase-1, GSDMD, IL-1β, and IL-18. The application of a CASP1 inhibitor reversed these alterations and mitigated ROS accumulation.

Conclusion

This study suggests that CASP1 is a central molecular component in DED. BPA promotes ocular surface injury by activating the CASP1/GSDMD-mediated pyroptotic axis and its associated inflammatory cascade. Inhibition of CASP1 effectively abrogates this process, suggesting potential avenues for clinical intervention.

Keywords: bisphenol A, dry eye disease, mendelian randomization, molecular docking, network toxicology

1. Introduction

Bisphenol A (BPA) is an industrial chemical produced in large quantities and widely employed for the manufacture of epoxy resins and polycarbonate plastics (Xing et al., 2022; Tuzimski et al., 2019). Its extensive use in specialized paper products, medical materials, beverage and food packaging (Celar Sturm and Virant-Klun, 2023), and various consumer products has led to persistent and unavoidable human exposure (Guimarães et al., 2023; Harley et al., 2013). With global plastic production approaching 400 million tons per year, BPA contamination has become a growing concern in environmental and public health research. Exposure occurs primarily through ingestion and skin contact, allowing BPA to enter systemic circulation. As a representative endocrine-disrupting chemical, BPA can interfere with estrogen receptor–mediated signaling by exhibiting estrogenic activity, thereby perturbing endocrine regulation (Adamovsky et al., 2024). Evidence from experimental and epidemiological studies indicates that BPA exposure is linked to adverse health effects, including metabolic disorders, reproductive dysfunction, neurodevelopmental impairment, cardiovascular disease, and immune dysregulation (Costa and Cairrao, 2024; Hyun and Ka, 2024; Acconcia et al., 2015; Liu et al., 2022; Chen J. et al., 2025). Despite extensive investigation of its systemic toxicity, the effects of BPA on ocular tissues remain insufficiently characterized. In particular, its potential involvement in eye disease pathogenesis has received limited attention.

Dry eye disease (DED) is a disorder of the ocular surface characterized by a complex, multifactorial pathogenesis, with global prevalence estimates reported between 5% and 50%, with particularly elevated prevalence observed among Asian populations (Clayton, 2018). The principal hallmark of this ocular disorder is compromised tear film homeostasis, manifested by unstable tear dynamics and hyperosmolarity (Han et al., 2023), which drive a self-perpetuating pathogenic cycle (Rhee and Mah, 2017). Chronic inflammation of ocular surface, oxidative stress, neurosensory dysfunction, and epithelial barrier impairment are recognized as central mechanisms underlying DED (15). These pathological alterations lead to common clinical manifestations such as visual instability, ocular irritation and pain, resulting in substantial impairment of daily functioning and quality of life (Zemanová, 2021). Established risk factors include aging, female sex, genetic predisposition, and hormonal imbalance, highlighting the complexity of DED etiology (Britten-Jones et al., 2024; Qian and Wei, 2022). Increasing evidence indicates that environmental exposures act as external modifiers of ocular surface health and may interact with intrinsic molecular pathways to promote or exacerbate DED (Lin et al., 2022; Alves et al., 2023; Rauchman et al., 2023).

Recent evidence shows that BPA exposure disrupts immune homeostasis and activates inflammatory signaling pathways, processes that are integral to DED pathogenesis (Ma et al., 2019; Hong et al., 2024; Huang et al., 2023). These observations indicate that chronic BPA exposure could contributes to the development or exacerbation through immune and inflammatory dysregulation at the ocular surface. BPA is widely present in various media including indoor dust and settled particles (Zhu et al., 2023; Li et al., 2024; Pan et al., 2024; Lv et al., 2016). The ocular surface is directly open to the external environment. Therefore, corneal cells are continuously vulnerable to surrounding toxins. Meanwhile, increasing evidence demonstrates that common environmental pollutants can directly disrupt ocular surface homeostasis. For example, certain atmospheric contaminants alter the corneal epithelium and cause a significant loss of conjunctival cells (Torricelli et al., 2014; Yang et al., 2019). These parallel findings justify the evaluation of whether bisphenol A induces similar toxicity in corneal epithelial cells. This context provides a logical basis for utilizing a direct cellular model in our study. However, systematic investigation of the molecular interplay between BPA exposure and DED is currently lacking.

Given the complexity of both BPA toxicity and DED pathogenesis, conventional reductionist approaches are inadequate for capturing system-level interactions between environmental exposure and disease. Network toxicology integrates bioinformatics and multi-omics data to construct compound–target–pathway–disease networks and identify key molecular mediators (Sturla et al., 2014; Zhang et al., 2020). We designed a framework incorporating network toxicology, Mendelian randomization, and experimental validation (Karthikeyan et al., 2019; Li et al., 2025). This approach serves to propose potential hypotheses and provide preliminary validation rather than definitive proof of causality. This multi-level strategy aims to elucidate the molecular mechanisms between BPA exposure and DED and to provide mechanistic insight into the environmental contribution to ocular surface disease.

2. Materials and methods

2.1. Toxicity analysis

The Simplified Molecular Input Line Entry System (SMILES) notation of bisphenol A was obtained from PubChem and submitted to ProTox 3.0 to predict molecular initiating events, target pathway activities, and metabolic specificities. ADMETlab 3.0 was utilized to assess multidimensional safety endpoints.

2.2. Target prediction for BPA and DED

Experimentally validated chemical target interactions from the Comparative Toxicogenomics Database were prioritized as the primary candidates. Supplementary predictions were obtained from SwissTargetPrediction, PharmMapper, ChEMBL, STITCH, and SEA, with analyses restricted to Homo sapiens. Target identifiers were standardized using UniProt, and duplicate entries were removed after integration. These candidates were subsequently filtered using corneal tissue specific differentially expressed genes to identify targets with disease relevance. DED associated genes were collected from OMIM and GeneCards to generate the unified disease target list.

2.3. Identification of DED-associated differentially expressed genes

DED-related transcriptomic data were acquired from the Gene Expression Omnibus (GEO) platform. Two datasets were incorporated: GSE252984 (platform GPL24247), containing 4 control corneal samples and 4 DED corneal samples, and GSE208297 (platform GPL24247), comprising 5 control corneal samples and 5 DED corneal samples. Raw expression profiles were analyzed in R with the limma package. Duplicate probes were removed, and expression values were normalized with the normalizeBetweenArrays function. For datasets generated on the same platform, ComBat from the sva package was used to correct batch effects. To validate this correction, principal component analysis was performed (Supplementary Figure S1). Differentially expressed genes (DEGs) analysis was performed with limma, and genes meeting the criteria of adjusted P < 0.05 and |log2 fold change| > 1 were retained. Mouse genes were converted to their corresponding human orthologs using the NCBI HomoloGene database.

2.4. Functional and pathway enrichment analysis

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were applied to examine functional characteristics of the identified target genes (P value <0.05). GO analysis was used to assess enrichment in cellular components, molecular functions, and biological processes. KEGG analysis was subsequently conducted to identify signaling pathways potentially related to BPA involvement in DED.

2.5. Protein–protein interaction (PPI) network construction and core target screening

PPI analysis was carried out with the STRING database (Szklarczyk et al., 2023; Chi et al., 2024). Target genes were uploaded under a Homo sapiens constraint, with an interaction confidence threshold set at 0.4. PPI network visualization and analysis were carried out in Cytoscape (Majeed and Mukhtar, 2023; Chen T. et al., 2025). We employed the CytoHubba tool to determine core genes in the network based on several topological metrics, and genes that ranked highly across multiple methods were selected.

2.6. Machine learning–based identification of core genes

An integrated strategy involving Random Forest, Support Vector Machine (SVM), and Least Absolute Shrinkage and Selection Operator (LASSO) regression was executed to screen for core genes associated with BPA-related DED. The random forest model was implemented using the “randomForest” package, and gene importance was evaluated using the Gini index. For SVM analysis, a classifier incorporating a radial basis function kernel was established via the “caret” environment, and feature selection was performed by SVM-RFE with 5-fold cross-validation. LASSO regression was conducted using the “glmnet” packagewith the optimal λ identified through 5-fold cross-validation. Genes with non-zero coefficients were selected. The intersection of three methods was selected for downstream analyses.

2.7. Mendelian randomization

Two-sample Mendelian randomization analysis was used to examine the potential causal effect of candidate gene expression on the phenotype. Genetic variants associated with gene expression were obtained from expression quantitative trait loci (eQTL) data sourced from whole blood samples in the eQTLGen consortium under the dataset identifier eqtl a ENSG00000137752. Outcome-related effects were derived from genome-wide association study (GWAS) summary statistics (GCST90043801). All datasets were publicly available. Single nucleotide polymorphisms (SNPs) significantly associated with the exposure were used as instrumental variables (P < 5 × 10−8). Independence among instruments was ensured by linkage disequilibrium (LD) clumping with an r2 threshold of 0.001 and a 10 kb window. Instrument strength was evaluated based on the F-statistic, with F-statistic >10 considered indicative of sufficient strength. The Inverse Variance Weighted (IVW) served as the primary method for causal estimation. Pleiotropy, heterogeneity, and the influence of individual SNPs were assessed using MR-Egger regression, Cochran’s Q statistics, and leave-one-out analyses. Analysis was conducted with the TwoSampleMR package (v0.5.7) in R.

2.8. Gene set enrichment analysis

GSEA was applied to further characterize biological processes and pathways associated with hub genes. Analysis was carried out with the “clusterProfiler” package and the “m5.go.v2025.1.Mm.symbols.gmt” gene set from Molecular Signatures Database (MSigDB). Genes were ranked by Spearman correlation coefficients, and significant enrichment was defined by false discovery rate (FDR) < 0.25 and |normalized enrichment score (NES)| > 1 (P < 0.05).

2.9. Immune infiltration analysis

Gene expression profiles from DED and control samples were analyzed to estimate the composition of immune cell with CIBERSORT. Statistical analysis was performed to identify cell populations showing proportional variations between the studied conditions (P < 0.05). Associations between immune cell proportions and core biomarkers were analyzed using correlation analysis.

2.10. Molecular docking analysis and molecular dynamics simulation

We conducted computational docking to evaluate the spatial engagement between BPA and the key target. An analytical protocol was adopted where the ligand retained its conformational freedom against a static macromolecular receptor. The spatial conformation of the target was sourced from the AlphaFold repository. Protein structure was prepared using PyMOL (version 3.1) by removing co-crystallized ligands and water molecules. The resulting structure was optimized using AutoDock Tools and AutoDock Vina (version 1.5.6). For each protein, a docking grid covering the predicted binding site was defined, and ten independent docking runs were conducted. Docking results were evaluated based on binding conformations and binding energy. Interactions were visualized using PyMOL. To validate the thermodynamic stability of the docked complex under physiological conditions, a one hundred nanosecond molecular dynamics simulation was executed using the Gromacs 2025 software package. The protein was parameterized using the AMBER14SB force field, and the ligand topology was constructed using the GAFF2 force field. The topology files were merged to ensure zero atom type conflicts. Periodic boundary conditions were implemented, placing the complex in a cubic box with a minimum distance of 1.2 nm from the solute to the box wall. The system was solvated using the TIP3P water model. Sodium and chloride ions were added at a concentration of 0.15 M to neutralize the net charge and mimic the physiological environment. Following energy minimization, the system underwent NVT and NPT equilibrations with a coupling constant of 0.1 picoseconds for a total duration of 2 nanoseconds. The production molecular dynamics run was carried out at a constant temperature of 310 K and a constant pressure of 1 bar for one hundred nanoseconds, employing a time step of two femtoseconds. Trajectory properties including root mean square deviation, root mean square fluctuation, radius of gyration, solvent accessible surface area, and hydrogen bond count were calculated using standard Gromacs utilities. The average binding free energy and individual residue energy decompositions were calculated using the MMPBSA method over the stable equilibrium trajectory. The Gibbs free energy landscape was plotted based on the first two principal components to characterize the thermodynamic equilibrium states.

2.11. Cell culture and treatment

Human immortalized corneal epithelial cells (HCECs; Procell, Wuhan, China) were cultured in DMEM/F12 medium (Meilunbio, Dalian, China) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. Cultures were maintained in conventional cell culture incubators (37 °C, 5% CO2). Cells reached 80%–85% confluence before the medium was replaced with concentrations of bisphenol A (BPA; TargetMol, Shanghai, China) at 0.1, 1, 10, or 100 μM. Cells were harvested after 24 h of exposure. To evaluate the role of caspase-1, the inhibitor Ac-YVAD-CHO (10 μM; TargetMol) was added to the medium during BPA treatment. Control groups received an equivalent volume of DMSO as a vehicle.

2.12. Cell Counting Kit-8 (CCK-8) assay

Cellular survival was quantified via the CCK-8 assay. HCECs were seeded into 96-well plates and incubated for 24 h for stable adherence. Following exposure to various concentrations of BPA for another 24 h, the culture medium was replaced with 100 μL of fresh medium containing 10 μL of CCK-8 solution (Solarbio, Beijing, China). After a 2 h incubation in the dark, the optical density (OD) at 450 nm was measured.

2.13. Lactate dehydrogenase (LDH) release assay and propidium iodide (PI) staining assay

Cytotoxicity was quantified by measuring the release of LDH into the culture supernatant using an LDH assay kit (Meilunbio, Dalian, China). High-control wells were treated with 10 μL of Lysis Buffer 30 min prior to the end of the 24 h BPA treatment. After centrifugation at 250 × g for 2 min, 100 μL of the supernatant was transferred to a new plate and mixed with 100 μL of LDH reaction mixture. Following a 30 min incubation at room temperature, the reaction was stopped, and absorbance was measured at 490 nm.

For the assessment of cell membrane permeability, a propidium iodide (PI) reagent (Meilunbio, Dalian, China) was employed at a working concentration of 20 μg/mL. The experimental treatment of human corneal epithelial cells was identical to the conditions described for the LDH release assay. Following the exposure window, the cells were incubated with the propidium iodide working solution at 37 °C for 20 min in the dark. Subsequently, nuclei were counterstained with DAPI (Solarbio) for 5 min. High resolution fluorescence images were captured utilizing an inverted fluorescence microscope, and the proportion of propidium iodide positive cells was quantified using ImageJ software.

2.14. Reactive oxygen species (ROS) detection

Intracellular ROS levels were evaluated using the fluorescent probe DCFH-DA. HCECs were seeded in 12-well plates and subjected to the indicated treatments (100 μM BPA with or without 10 μM Ac-YVAD-CHO) for 24 h. Cells were washed with PBS and incubated with 10 μM DCFH-DA for 20 min at 37 °C in the dark. After three washes with serum-free medium to remove the extracellular probe, cells were fixed with 4% paraformaldehyde for 15 min. Nuclei were counterstained with DAPI (Solarbio) for 5 min at room temperature. Fluorescence images were captured using an inverted fluorescence microscope. Fluorescence intensity was quantified using ImageJ software. A uniform threshold setting was applied consistently across all captured images.

2.15. RNA isolation and quantitative real-time PCR (qRT-PCR)

Total RNA was extracted from HCECs using a column-based RNA isolation kit (Vazyme, Nanjing, China). One microgram of total RNA was reverse-transcribed into cDNA using the HiScript III RT SuperMix (Vazyme). Quantitative real-time PCR was performed on a Bio-Rad CFX96 real-time PCR system (Bio-Rad, Hercules, CA, USA) using the ChamQ Universal SYBR qPCR Master Mix (Vazyme). The thermal cycling protocol consisted of an initial denaturation at 95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 10 s, and annealing or extension at 60 °C for 30 s. The relative mRNA expression levels of caspase-1, GSDMD, IL-1β, and IL-18 were calculated using the 2−ΔΔCt method. β-actin was used as the endogenous control for normalization. The primer sequences used are as follows (Table 1).

TABLE 1.

Information of primers used for RT-qPCR.

Target gene Forward Reverse
GSDMD 5′-ACT​GAG​GTC​CAC​AGC​CAA​GAG​G-3′ 5′-GCC​ACT​CGG​AAT​GCC​AGG​ATG-3′
caspase-1 5′-ATA​CAA​CCA​CTC​GTA​CAC​GTC​TTG​C-3′ 5′-TCC​TCC​AGC​AGC​AAC​TTC​ATT​TCT-3′
IL-1β 5′-TCG​CAG​CAG​CAC​ATC​AAC​AAG-3′ 5′-TCC​ACG​GGA​AAG​ACA​CAG​GTA​G-3′
IL-18 5′-GTC​GCA​GAT​GGC​TCT​TTG​CT-3′ 5′-TGC​CAA​AGT​AAT​CTG​ATT​CCA​GGT-3′
β-actin 5′-TGG​CAC​CCA​GCA​CAA​TGA​A-3′ 5′-CTA​AGT​CAT​AGT​CCG​CCT​AGA​AGC​A-3′

All primer sequences listed above correspond to Homo sapiens transcripts.

2.16. Western blot analysis

Human immortalized corneal epithelial cells were lysed with RIPA lysis buffer (Solarbio, Beijing, China). Protein concentrations were measured by BCA assay, mixed with SDS sample buffer, and boiled for 10 min at 95 °C. The protein samples were separated by 10%–12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) and transferred onto a polyvinylidene difluoride (PVDF) membrane. The membranes were blocked with 5% skimmed milk at room temperature for 2 h and then incubated with primary antibodies diluted by antibody dilution buffer (Beyotime, Shanghai, China) at 4 °C overnight. Primary antibodies obtained from Wanlei Bio (Shenyang, China) included those against cleaved caspase 1, GSDMD, mature IL 1β, mature IL 18, and β-actin. The following day, the membranes were washed with 1× Tris buffered saline and Tween 20 (TBST) three times and incubated with secondary antibodies at room temperature for 1 h. Protein expression levels were tested with a chemiluminescence assay (Thermo Fisher Scientific, Waltham, MA, United States). The ratio of the gray value of the target band to β-actin was representative of the relative protein expression.

2.17. Statistical analyses

Statistical analyses and data visualization were performed using R software (version 4.4.2) and GraphPad Prism 10. All quantitative experiments were performed independently at least three times. Data are presented as the mean ± standard deviation (SD). Differences between two groups were evaluated using Student’s t-test, while comparisons among multiple groups were assessed via one-way analysis of variance (ANOVA). Statistical significance was defined as P < 0.05.

3. Result

3.1. Toxicity prediction

BPA exhibited blood-brain barrier (BBB) permeability and ecotoxicity in ProTox 3.0 simulations. Molecular initiating events suggested high binding probabilities for transthyretin (TTR) and pregnane X receptor (PXR). Pathway analysis indicated targeted activity toward estrogen receptor alpha (ERα) and interference with mitochondrial membrane potential (MMP). BPA was further categorized as a potential substrate for the cytochrome P450 enzymes CYP2C19 and CYP2C9 (Table 2; Figure 1). Multidimensional toxicity assessment via ADMETlab 3.0 revealed high risks for ocular irritation, corrosion, and skin sensitization. Predicted systemic toxicities included hERG channel blockade, significant neurotoxicity, and potent cytotoxicity against A549 and HEK293 cell lines (Table 3; Figure 2). These findings define BPA as a hazardous agent with specific potential for ocular surface damage.

TABLE 2.

Toxicity prediction-ProTox 3.0

Classification Target Prediction Probability
Toxicity end points Ecotoxicity Active 0.63
Toxicity end points BBB-barrier Active 0.53
Molecular Initiating Events Pregnane X receptor Active 0.66
Molecular Initiating Events Transtyretrin Active 0.74
Tox21-Nuclear receptor signalling pathways Estrogen Receptor Alpha Active 1
Tox21-Nuclear receptor signalling pathways Estrogen Receptor Ligand Binding Domain Active 1
Tox21-Stress response pathways Mitochondrial Membrane Potential Active 1
Metabolism CYP2C19 Active 0.68
Metabolism CYP2C9 Active 0.77

FIGURE 1.

Panel A shows the chemical structure of an organic molecule with two phenol groups attached to a central isopropylidene bridge. Panel B includes a radar chart displaying activity probabilities across various biological targets and two circular network diagrams, one labeled "Inactive cluster" with mostly green nodes, and one labeled "Active cluster" with mostly red nodes, illustrating predicted biological activity or inactivity for different molecular interactions.

Molecular Structure and Toxicity Map of Bisphenol A. (A) Molecular formula of BPA; (B) Toxicity map of BPA.

TABLE 3.

Toxicity prediction-Admetlab 3.0

Classification Probability
hERG Blockers 0.228
hERG Blockers (10um) 0.837
DILI 0.04
FDAMDD 0.614
Rat Oral Acute Toxicity 0.275
AMES Toxicity 0.109
Genotoxicity 0.043
Hematotoxicity 0.052
Ototoxicity 0.316
Drug-induced Neurotoxicity 0.742
Drug-induced Nephrotoxicity 0.074
Human Hepatotoxicity 0.295
Respiratory 0.462
Eye Irritation 0.998
Eye Corrosion 0.843
Carcinogenicity 0.239
Skin Sensitization 0.846
RPMI-8226 Immunitoxicity 0.032
A549 Cytotoxicity 0.701
Hek293 Cytotoxicity 0.785

FIGURE 2.

Radar chart illustrating toxicity data across multiple categories including cytotoxicity, immunotoxicity, genotoxicity, hematotoxicity, neurotoxicity, nephrotoxicity, hepatotoxicity, DILI, AMES toxicity, acute oral toxicity, skin sensitization, carcinogenicity, eye irritation, and respiratory effects, with a red-shaded area representing the overall toxicity values.

Toxicity radar chart.

3.2. Candidate target identification of DED induced by BPA

Prioritizing experimentally validated interactions in the Comparative Toxicogenomics Database and integrating complementary predictions from SwissTargetPrediction, PharmMapper, ChEMBL, STITCH, and SEA identified 207 unique BPA related targets. In parallel, 2,858 DED-associated genes were retrieved from OMIM and GeneCards. Overlap analysis between these two sets yielded 104 candidate targets (Figure 3).

FIGURE 3.

Venn diagram comparing two sets labeled DED and BPA. DED contains 2754 unique items, BPA contains 103 unique items, and there are 104 items shared between both sets.

Venn diagram showing the overlap between targets of DED and BPA.

To refine these candidates based on disease-specific expression profiles, we analyzed the GSE252984 and GSE208297 datasets, identifying 1,282 DEGs (677 upregulated and 605 downregulated). These DEGs were visualized using a volcano plot (Figure 4A). A heatmap of the top 50 DEGs with the largest expression changes demonstrated distinct transcriptional differences between DED and control samples (Figure 4B). Mapping these sequences to human orthologs resulted in 1,151 genes. The final intersection of these 1,151 orthologs with the 104 initial candidates prioritized 12 core targets (CA2, GSR, PTGS2, ADORA1, PTPRC, CASP1, TNF, BCL2, CASP3, VEGFA, CD36, and MYB) for further investigation (Figure 4C).

FIGURE 4.

Panel A displays a volcano plot comparing CON and DED groups, highlighting significant upregulated genes in red, downregulated genes in blue, and non-significant genes in gray, with several genes labeled by name. Panel B presents a heat map of gene expression, split between CON and DED samples, using a color gradient from red to blue to represent relative expression levels, with gene names listed on the side. Panel C shows a Venn diagram comparing candidate targets and differentially expressed genes, with 92 genes unique to candidate targets, 1139 unique to DEGs, and 12 genes overlapping.

Identification of DEGs in dry eye disease. (A) Volcano plot; (B) Heatmap; (C) Venn diagram.

3.3. Functional enrichment analysis

We subjected the overlapping genes to functional profiling within the R environment, referencing both the GO and KEGG databases. KEGG pathway analysis identified 72 significantly enriched pathways. The top 30 pathways (Figures 5A,B) were primarily associated with classical pro-inflammatory cascades (IL-17, TNF, and NF-κB signaling) and programmed cell death. Enrichment was also observed in stress and metabolic networks, such as the AGE-RAGE signaling pathway. GO enrichment analysis identified 1,421 significant terms, including 76 molecular functions (MFs), 24 cellular components (CCs), and 1,321 biological processes (BPs). As visualized in Figures 5C,D, BPs centered on responses to hypoxia, oxidative stress, and toxic substances. Cellular components mapped to the Bcl-2 family protein complex and membrane rafts, while molecular functions were characterized by cytokine receptor binding and antioxidant activity. These profiles indicate that the core targets mediate oxidative imbalance and aberrant inflammatory signaling at the ocular surface.

FIGURE 5.

Panel A displays a horizontal bar graph ranking biological pathways by count with a color gradient indicating adjusted p-values (q-value). Panel B presents a dot plot ranking the same pathways by gene ratio, where dot size reflects gene count and color represents q-value. Panel C shows a horizontal bar graph ranking gene ontology terms in three categories—biological process, cellular component, and molecular function—by count and colored by q-value. Panel D presents a corresponding dot plot for gene ontology terms, with dot size indicating gene count and color for q-value, and arranged by gene ratio.

GO and KEGG Analysis. (A) and (C) Bar chart; (B) and (D) Bubble chart.

3.4. PPI network and identification of core targets

To map the interaction landscape of the 12 candidate targets, we acquired the protein-protein crosstalk data from the STRING repository. PPI network was rendered in Cytoscape (Figures 6A,B). Network topology was evaluated utilizing four distinct algorithms: Degree, Maximum Neighborhood Component (MCC), Closeness, and Betweenness centrality (Figures 6C–F). The top eight nodes from each algorithmic ranking were intersected for further analysis (Figure 6G).

FIGURE 6.

Panel A shows a network diagram of protein-protein interactions among ten labeled proteins with nodes and connecting lines. Panels B through F display colored circular network graphs representing different gene interaction metrics, with node color intensity indicating importance. Panel G is a Venn diagram with four color-coded sets labeled Degree, MCC, Closeness, and Betweenness, showing overlapping and unique central genes with counts listed in each section.

PPI network and topological screening of hub genes. (A) The PPI network for BPA targtes in DED. (B) PPI network in Cytoscape v3.10.0, showing proteins as nodes and interactions as edges. (C–F) Identification of the top eight targets based on four topological algorithms: degree (C), MCC (D), closeness (E), and betweenness (F). (G) Venn diagram.

3.5. Machine learning–based identification of core genes

Three machine learning methods were applied. For the LASSO framework, 5-fold cross-validation was executed to determine the optimal regularization parameter (λ = 0.02019473) (Figures 7A,B), under which CASP1 and TNF were retained. SVM-RFE analysis was subsequently performed to evaluate feature importance. The highest classification accuracy was achieved when one gene, CASP1, was retained (Figure 7C). Random forest analysis ranked genes according to their importance scores, with CASP1 showing the highest score, followed by PTGS2, PTPRC, TNF, CASP3, and BCL2 (Figures 7D,E). Results identified CASP1 as the most prominent core gene associated with BPA-related DED.

FIGURE 7.

Figure with five panels displays model selection and gene importance analyses. A: Line plot showing coefficient paths versus negative log lambda for LASSO regression. B: Mean-squared error versus negative log lambda with red dots and error bars guiding lambda selection. C: Line plot of cross-validation accuracy versus number of features, peaking at one feature. D: Random forest error vs. number of trees, with error rapidly decreasing near zero. E: Horizontal bar chart ranking top genes by importance, highlighting CASP1 and PTGS2 as most important and BCL2 as least, with color gradient indicating importance values.

Core gene identification via machine learning algorithms for BPA-induced DED (A,B) LASSO algorithm. (C) SVM-RFE algorithm. (D,E) Random forest algorithm.

3.6. Mendelian randomization

MR analysis was used to evaluate the causal relationship between CASP1 expression and DED risk, with CASP1 expression as the exposure and DED as the outcome. Using the IVW method, higher CASP1 expression was linked to a higher risk of DED (β = 0.102, SE = 0.023, P = 8.17 × 10−6), corresponding to an OR of 1.11 (95% CI: 1.06–1.16). Consistent effect estimates were observed using complementary MR methods. The weighted median method yielded an OR of 1.11 (95% CI: 1.04–1.17, P = 6.19 × 10−4), while MR-Egger regression showed an OR of 1.19 (95% CI: 1.09–1.31, P = 2.78 × 10−4) (Table 4; Figure 8). Sensitivity analyses showed no significant heterogeneity among instrumental variables (IVW Cochran’s Q = 103.66, P = 0.11; MR-Egger Q = 99.72, P = 0.15). The MR-Egger intercept test did not show presence of horizontal pleiotropy (intercept = −0.036, P = 0.069). Leave-one-out analysis showed that the association was not driven by individual SNPs.

TABLE 4.

The Causal association between CASP1 expression and the risk of DED.

Method nsnp OR P-value
MR Egger 88 1.193,815 2.78 × 10−4
Weighted median 88 1.107,859 4.12 × 10−4
Inverse variance weighted 88 1.107,001 8.17 × 10−6
Simple mode 88 1.002060 9.66 × 10−1
Weighted mode 88 1.066471 6.76 × 10−2

FIGURE 8.

Panel A displays a scatter plot showing SNP effect on exposure versus SNP effect on outcome, with multiple Mendelian randomization estimate lines and error bars; panel B presents a forest plot of individual SNP effect sizes and confidence intervals; panel C shows a funnel plot with inverse standard error versus beta estimates comparing two MR methods; panel D contains a leave-one-out sensitivity analysis plot with effect size estimates for each SNP, demonstrating consistency of results.

Mendelian randomization analyses assessing the causal effect of CASP1 expression on dry eye disease. (A) Scatter plot illustrating the associations between single nucleotide polymorphism (SNP) effects on CASP1 expression (exposure) and dry eye disease risk (outcome). Each point represents an individual SNP, with regression lines corresponding to different MR methods. (B) Forest plot showing the individual causal estimates for each SNP on dry eye disease, along with the pooled estimates derived from the IVW and MR-Egger methods. Horizontal lines indicate 95% confidence intervals. (C) Funnel plot assessing potential directional pleiotropy. (D) Leave-one-out sensitivity analysis.

3.7. Gene set enrichment analysis

GSEA was performed based on gene rankings according to their Spearman correlation with CASP1 expression across the transcriptome. This approach allowed the identification of coordinated pathway-level changes independent of arbitrary differential expression thresholds. The overall enrichment results are shown in Figure 9A. Genes positively correlated with CASP1 expression were significantly enriched in pathways associated to mitochondrial energy metabolism and protein synthesis. These pathways included ATP synthesis coupled electron transport, aerobic respiration, respiratory chain complex organization and oxidative phosphorylation. Multiple ribosome-related gene sets, such as structural constituent of ribosome and ribosomal subunit, showed significant positive enrichment (Figure 9A). When enrichment results were examined by direction, metabolic and translational pathways were mainly positively enriched, whereas gene sets related to transcriptional regulation and RNA processing were negatively enriched (Figures 9B,C). Enrichment plots of representative gene sets further demonstrated strong enrichment of ribosome-associated pathways (Figure 9D). These findings indicate a distinct transcriptomic reprogramming coupled with CASP1 activation, characterized by amplified energetic and translational activities alongside suppressed RNA metabolism.

FIGURE 9.

Panel A displays a bubble plot of gene ontology enrichment, with gene ratios on the x-axis, categories on the y-axis, dot color indicating normalized enrichment score, and size reflecting gene count. Panel B shows a bubble plot comparing activated and suppressed gene sets, with gene ratios on the x-axis, categories on the y-axis, dot color for adjusted p-value, and size for gene count. Panel C presents an enrichment score line plot for several gene sets, displaying the running enrichment score across the ranked gene list. Panel D consists of three enrichment plots for specific ribosome-related gene sets, with enrichment scores and gene positions indicated.

GSEA of CASP1-associated transcriptional programs. (A) Dot plot summarizing significantly enriched GO terms identified by GSEA based on genes ranked according to their Spearman correlation with CASP1 expression. (B) Dot plot showing enriched GO terms stratified by the direction of enrichment. Pathways with positive and negative NES values are displayed separately (C) Combined visualization of positively and negatively enriched pathways. (D) Individual GSEA enrichment plots for representative top positively enriched pathways.

3.8. Immune infiltration analysis

Pairwise correlation analysis among immune cell subsets showed structured co-variation patterns across samples (Figure 10A). Immune cell composition differed between control groups and DED, revealing an overall redistribution of immune cell proportions (Figure 10B). Differential abundance analysis identified several immune cell types with significant differences between groups. Compared with control group, M0 macrophages were significantly increased in the DED group (P < 0.001; Figure 10C). Heatmap visualization further demonstrated consistently higher proportions of M0 macrophages in DED samples (Figure 10D). Across all samples, CASP1 expression showed a positive correlation with M0 macrophage abundance (Figure 10E). M0 macrophage proportions were also significantly higher in DED samples than in controls on a per-sample basis (Figure 10F). However, this association dissipated upon group stratification, manifesting a classic Simpson’s paradox. Although a strong positive correlation was observed in the combined dataset (Pearson r = 0.788, P = 1.03 × 10−4), no significant correlation was detected within either the control group (r = −0.234, P = 0.544) or the DED group (r = 0.289, P = 0.450) (Figure 10G). Variance decomposition analysis indicated that disease status (DED vs. control) accounted for approximately 64.7% of the explained variance in M0 macrophage infiltration, whereas CASP1 expression contributed minimally within groups (approximately 0.4%), with the remaining variance unexplained (Figure 10H).

FIGURE 10.

Panel A shows a correlation matrix with colored circles representing correlations between immune cell types. Panel B presents a stacked bar graph comparing immune cell composition between control and DED groups. Panel C displays a box plot of immune cell proportions in each group. Panel D is a clustered heatmap of immune cell abundance with color-coded groups. Panel E is a dot plot showing correlation coefficients for immune cell types, with dot size indicating statistical significance. Panel F features a violin plot comparing Macrophage M0 levels between groups, indicating significance. Panel G is a scatter plot showing a positive correlation between CASP1 expression and Macrophage M0 abundance. Panel H shows a bar chart decomposing Macrophage M0 variance, highlighting that group identity explains most of the variance.

Immune infiltration analysis. (A) Pairwise correlation heatmap of immune cell proportions. (B) Immune cell composition in DED and control groups. (C) Differential abundance analysis of immune cell proportions. (D) Heatmap depicting the standardized abundance of immune cell types. (E) Bubble plot illustrating correlations between CASP1 expression and immune cell proportions. Bubble size indicates adjusted significance level, and color represents correlation direction and magnitude. (F) Violin plot comparing Macrophages M0 proportions between control and DED groups. (G) The relationship between CASP1 expression and Macrophages M0 proportion. (H) Variance decomposition of Macrophages M0 abundance based on a linear model.

3.9. Molecular docking analysis and molecular dynamics simulation

Molecular docking predicted a potential initial non covalent engagement between BPA and the active site of CASP1, generating a docking score of minus 5.1 kcal per mol (Figure 11A). In this static snapshot, the hydroxyl groups of the ligand establish primary hydrogen bonds with the residues Asn337 and Gln385. To characterize the dynamic evolution and thermodynamic stability of this interaction under simulated physiological environments, a one hundred nanosecond molecular dynamics trajectory was analyzed. The root mean square deviation curves demonstrate that the complex achieves structural equilibrium rapidly after 20 ns. The backbone coordinates of the receptor and the ligand protein complex remained highly synchronized, and the ligand root mean square deviation fluctuated within an exceptionally low range, indicating that BPA remains securely anchored within the pocket without undergoing dissociation or substantial displacement (Figure 11B). Local residue flexibility analysis via root mean square fluctuations confirmed high rigidity across the core functional domains of the protein, while flexible behavior was confined to the terminal loops (Figure 11C). The radius of gyration and solvent accessible surface area values remained remarkably constant throughout the simulation window, confirming that the protein maintains a tight fold and preserves its hydrophobic core during ligand accommodation (Figures 11D,E). This structural integrity is sustained by a continuous network of intermolecular hydrogen bonds (Figure 11F). The total binding free energy calculated via the MMPBSA method was minus 12.19 kcal per mol, confirming a highly favorable and spontaneous thermodynamic process. Energy component analysis revealed that van der Waals interactions and gas phase energies serve as the principal driving forces for complex stabilization, whereas polar solvation energy acts as the primary destabilizing barrier (Figure 11G). Decomposition of the binding energy on a per residue basis indicated that residues MET386, VAL293, and VAL292 contributed the highest stabilizing energy (Figure 11H). Notably, while initial static docking highlighted hydrogen bonding at Asn337, the dynamic trajectory reveals an induced fit adaptation where the binding pocket reorganizes to optimize wider hydrophobic contacts anchored by MET386 and VAL293. Gibbs free energy landscape analysis further verified this behavior, mapping a single, continuous, deep blue energy minimum valley (Figures 11I,J). The lack of discrete high energy states demonstrates that the complex resides in a single dominant, thermodynamically stable conformation during the simulation.

FIGURE 11.

Panel A shows a molecular structure of a protein-ligand complex with an inset highlighting the binding site, key residues, and binding free energy value. Panel B presents a line graph comparing RMSD over time for CASP1, CASP1-BPA, and BPA alone. Panel C displays a line plot of RMSF versus residue number. Panel D features a blue line graph of radius of gyration across time. Panel E shows an orange line graph of solvent-accessible surface area over time. Panel F displays a bar chart of hydrogen bonds versus time. Panel G provides a bar graph of binding free energy components for CASP1-BPA. Panel H shows a red bar chart of per-residue binding free energies. Panel I presents a three-dimensional free energy surface plot colored by energy values. Panel J features a Gibbs energy landscape heatmap with axes labeled PC1 and PC2, and energy indicated by a color scale.

Molecular docking, molecular dynamics, and binding energy landscapes of the CASP1 BPA complex. (A) CASP1-BPA molecular docking diagram. (B) Root mean square deviation profiles of the protein, ligand, and complex over the one hundred nanosecond trajectory. (C) Root mean square fluctuation values per residue. (D) Radius of gyration showing structural compactness. (E) Solvent accessible surface area values. (F) Temporal distribution of intermolecular hydrogen bonds. (G) MMPBSA binding free energy components. (H) Decomposed binding energy contributions of key active site residues. (I) Three dimensional Gibbs free energy landscape showing the thermodynamic minimum valley. (J) Two dimensional Gibbs free energy landscape contour map.

3.10. In vitro validation of BPA-induced cytotoxicity and molecular mechanisms

3.10.1. BPA reduces HCEC viability and induces cytotoxicity

CCK-8, LDH release and propidium iodide staining assays were performed to evaluate the cytotoxicity of BPA (0.1, 1, 10, and 100 μM) on HCECs following a 24 h exposure. Cell viability remained unchanged at 0.1 and 1 μM (P > 0.05). However, LDH release increased significantly starting at 1 μM (P < 0.05). At 10 and 100 μM, HCECs exhibited a sharp decline in viability alongside a peak increase in LDH leakage (P < 0.0001; Figures 12A,B). Control cultures displayed negligible red fluorescence, whereas exposure to BPA led to a dose dependent surge in the relative propidium iodide positive cell ratio, confirming widespread membrane compromise that closely mirrors the LDH leakage profiles (Figures 12C,D). The 100 μM concentration stably induced significant membrane damage and was selected for subsequent mechanism experiments.

FIGURE 12.

Figure showing the effects of increasing BPA concentrations on cell health. Panels A-C show bar graphs: higher BPA decreases cell viability (A), increases LDH release (B), and increases PI positive cell ratio (C); statistical significance indicated. Panel D presents fluorescence microscopy images under each BPA condition, with rows for DAPI (blue, nuclei), PI (red, dead cells), and merged images, showing greater red signal with higher BPA.

BPA-induced cytotoxicity in human corneal epithelial cells (HCECs). (A) Cell viability measured by CCK-8 assay following 24 h exposure to BPA at 0.1, 1, 10, and 100 μM. (B) Lactate dehydrogenase (LDH) release into the culture supernatant. (C) Statistical quantification of the relative propidium iodide (PI) positive cell ratio illustrating dose-dependent membrane compromise. (D) Representative fluorescence micrographs showing DAPI (blue), PI (red), and merged channels in HCECs across the indicated concentration gradients. Scale bar = 100 μm (as indicated in the panels). All data are expressed as mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 vs. the control group.

3.10.2. BPA triggers intracellular ROS accumulation

Intracellular ROS levels were evaluated using the DCFH-DA probe. Control HCECs exhibited minimal background fluorescence. Exposure to 100 μM BPA for 24 h substantially intensified intracellular green fluorescence, and subsequent quantitative analysis showed a surge in relative ROS levels compared to the control group (P < 0.0001, Figure 13). Co-treatment with the CASP1 inhibitor Ac-YVAD-CHO attenuated this ROS accumulation. This indicates that BPA-induced oxidative imbalance in HCECs partially depends on anomalous CASP1 pathway activation.

FIGURE 13.

Panel A presents three sets of fluorescence microscopy images of cells stained with DAPI (blue, indicating nuclei) and DCFH-DA (green, indicating reactive oxygen species) under different treatment conditions: control, BPA, and BPA with Ac-YVAD-CHO. Green fluorescence is markedly increased in BPA-treated cells, reduced with Ac-YVAD-CHO co-treatment. Panel B shows a bar graph of relative fluorescence intensity, with BPA group significantly higher than control and BPA-AYC, as indicated by asterisks denoting statistical significance.

Promotion of intracellular ROS accumulation by BPA. (A) Fluorescence images showing DCFH-DA staining (green) in HCECs treated with 100 μM BPA and the CASP1 inhibitor Ac-YVAD-CHO (10 μM). Nuclei were counterstained with DAPI (blue). Scale bar = 100 μm. (B) Statistical quantification of relative ROS levels. Data are presented as mean ± SD (n = 3). BPA exposure triggered a ROS surge, which was partially mitigated by CASP1 inhibition. ****P < 0.0001. The custom label BPA-AYC denotes human corneal epithelial cells co treated with 100 μM BPA and 10 μM Ac-YVAD-CHO.

3.10.3. BPA activates CASP1-dependent pyroptosis and inflammation

To validate the predictions, the mRNA expression of pyroptosis markers and inflammatory cytokines was quantified via qRT-PCR. Compared to the control, 100 μM BPA treatment significantly upregulated the transcription of caspase-1 (P < 0.0001) and GSDMD (P < 0.001). This was accompanied by increased expression of IL-1β (P < 0.0001) and IL-18 (P < 0.01). The addition of Ac-YVAD-CHO suppressed the BPA-induced caspase-1 upregulation and reversed the elevated expression of GSDMD, IL-1β, and IL-18 (Figures 14A–D). Western blot analysis was executed (Figure 14E). Densitometric quantification revealed that BPA exposure triggered robust enzymatic cleavage events, evidenced by a substantial accumulation of cleaved caspase 1, mature IL 1β, and mature IL 18 proteins, alongside an increase in the executioner N GSDMD fragment (Figures 14F–I). Co. treatment with the caspase 1 inhibitor significantly suppressed the protein abundance of cleaved caspase 1, mature IL 1β, and mature IL 18. Although the protein level of the N GSDMD fragment exhibited a distinct downward trend upon caspase 1 inhibition, the statistical alteration between the BPA and BPA-AYC groups did not reach absolute significance (Figure 14G). These comprehensive molecular developments demonstrate that BPA drives corneal epithelial cell pyroptosis and downstream inflammatory cytokine maturation through the CASP1 GSDMD dependent signaling cascade.

FIGURE 14.

Nine-panel scientific figure showing bar graphs (A–D, F–I) and a western blot (E) comparing relative expression or protein levels of caspase-1, GSDMD, IL-1β, and IL-18 across three groups: NC (black), BPA (red), and BPA-AYC (blue or red). BPA exposure significantly increases these markers compared to NC, while BPA-AYC treatment reduces them. Panel E presents protein bands with molecular weights labeled. Statistical significance is indicated by asterisks above bars.

Activation of the CASP1 GSDMD dependent pyroptotic and inflammatory signaling axis by BPA in HCECs. (A–D) Relative mRNA expression levels of caspase-1 (A), GSDMD (B), IL-1β (C), and IL-18 (D) quantified via qRT PCR analysis. (E) Representative Western blot bands illustrating the protein expressions of N GSDMD, IL 18, cleaved caspase 1, IL 1β, and beta actin, with corresponding theoretical molecular weights annotated on the right. (F–I) Densitometric evaluation of relative protein levels for cleaved caspase 1 (F), N GSDMD (G), mature IL 1β (H), and mature IL 18 (I) normalized against the beta actin internal control. The custom label BPA-AYC denotes human corneal epithelial cells co treated with 100 μM BPA and 10 μM Ac YVAD CHO. All quantitative data are expressed as mean ± SD (n = 3). **Statistical significance is presented via capitalized italicized P values, where *P < 0.05, **P < 0.01, ***P < 0.001, **P < 0.0001, and ns indicates non significance.

4. Discussion

Dry eye disease (DED) is a multifactorial chronic disorder of the ocular surface. Persistent tear hyperosmolarity directly damages corneal and conjunctival epithelial cells (Stapleton et al., 2025). This damage triggers a local immune-inflammatory cascade and the release of inflammatory mediators, creating a vicious cycle that impairs visual quality (Messmer, 2015). Bisphenol A (BPA) is a classic environmental endocrine disruptor widely used in industrial products like plastics, resulting in high environmental abundance (Adamovsky et al., 2024). Humans ingest BPA primarily through the digestive tract, allowing it to enter the systemic circulation, from which it could hypothetically cross the blood tear barrier to reach the tear film, though definitive empirical validation of this specific transport pathway remains limited. Alternatively, direct environmental deposition represents a highly accessible exposure route; because the ocular surface is directly open to the external environment, corneal epithelial cells undergo continuous physical contact with contaminated indoor dust and settled microparticles. Structurally, BPA closely resembles endogenous estrogens. Its high lipophilicity allows it to easily penetrate biological membranes, including placental, blood brain, and ocular barriers, with the potential to accumulate in lipid rich tissues and cellular organelles (Ighalo et al., 2024). Although BPA has a short in vivo half-life of approximately 6 h, large-scale biomonitoring detects its metabolites in the urine of over 90% of tested individuals, indicating a high baseline exposure burden (Radwan et al., 2018). Previous systemic toxicology studies link BPA to oxidative stress and chronic inflammation in multiple organs (Le Corre et al., 2015), yet its specific effects on the ocular surface microenvironment lack mechanistic explanation. By integrating network toxicology, machine learning feature selection, Mendelian randomization, and in vitro experiments, this study systematically explored the link between BPA exposure and DED. The results show that BPA damages human corneal epithelial cells by triggering oxidative stress, which activates CASP1-mediated pyroptosis and inflammatory cytokine release.

Toxicity predictions using ADMETlab 3.0 and ProTox 3.0 indicated that BPA possesses significant ocular irritant, corrosive, and in vitro cytotoxic properties. Subsequent phenotypic experiments confirmed these predictions. As the first anatomical and immune barrier against environmental stress, the integrity of the corneal epithelium is essential for tolerating ocular surface hyperosmolarity and maintaining tear film dynamics (Baratta et al., 2022). CCK-8, LDH release, and propidium iodide staining assays showed that BPA exposure dose-dependently reduced HCEC viability and disrupted cell membrane integrity. This cytotoxicity corresponds to the microscopic pathological processes of DED, such as the destruction of corneal epithelial microvilli, degradation of intercellular tight junctions, and diffuse epithelial desquamation (Messmer, 2015). These findings provide direct experimental evidence for BPA-induced ocular surface damage.

Functional enrichment analysis indicated that BPA targets were enriched in pro-inflammatory signaling axes, including the NF-κB, TNF, and IL-17 pathways. BPA facilitates abnormal crosstalk between upstream signaling pathways to trigger the NF-κB axis, specifically through TLR4 activation and interference with ERK networks. In the gonads and central nervous system, these molecular events drive oxidative stress and subsequent tissue degeneration (Meng et al., 2020; Wang et al., 2025; Sevastre-Berghian et al., 2022). Beyond direct signaling, BPA remodels the local immune-metabolic microenvironment. This shift promotes the synthesis of IL-17 and TNF-α within adipose tissues and autoimmune-targeted organs (Hong et al., 2023; Dong et al., 2023), and has even been implicated in the inflammatory hyperplasia of the prostate stroma and structural degradation of the spleen (Wang et al., 2022; Xu et al., 2024a). Across diverse physiological contexts, BPA is consistently reported to induce NF-κB, TNF, and IL-17 signaling cascades. NF-κB signaling serves as a central axis in the inflammatory response, and its activation functioning is a primary driver of DED progression. In epithelial cells, hyperosmotic stress and environmental insults trigger NF-κB, directly inducing the release of mediators such as TNF-α and IL-1β (Chu et al., 2024; Zhu et al., 2025; Lin et al., 2025). IL-17 is a key marker of chronic immune injury in DED and synergizes with TNF to disrupt corneal barrier integrity and amplify localized inflammatory cascades (Kim et al., 2025; Garbutcheon-Singh et al., 2019). These mechanisms align with our GO analysis, which highlights oxidative stress and toxicity. Our in vitro experiments provided further validation: DCFH-DA staining revealed pronounced ROS accumulation in HCECs following BPA exposure. This redox imbalance causes direct structural damage to the ocular surface barrier and stimulates pro-inflammatory cytokine synthesis, thereby accelerating the pathological process.

Machine learning algorithms identified CASP1 as the most stable core gene. While the feature selection process also highlighted TNF, a detailed comparison justifies our focus on CASP1. In terms of topological positions within the interaction network, TNF acts as a broad upstream hub associated with systemic immune responses. In contrast, CASP1 occupies a distinct position tightly linked to the machinery of cellular death. Functionally, TNF regulates general leukocyte recruitment and cytokine cascades. Meanwhile, CASP1 specifically executes pyroptosis by cleaving gasdermin D. This cleavage directly leads to physical cell membrane rupture and corneal epithelial barrier dysfunction. Regarding druggability, current TNF inhibitors are primarily systemic biologics. These agents carry risks of profound immunosuppression and are difficult to formulate for stable ocular delivery. On the other hand, CASP1 represents an intracellular enzymatic target. This characteristic makes it highly suitable for the development of small molecule inhibitors designed for topical ophthalmic application. Therefore, CASP1 offers a more precise and practical target for localized intervention in DED. Mendelian randomization demonstrated that increased CASP1 expression causally elevates DED risk (OR = 1.11), with no indication of heterogeneity or horizontal pleiotropy. Machine learning and Mendelian randomization suggest that CASP1 is a key component in the pathology and susceptibility of DED. And the connection between the toxicant and CASP1 activation is confirmed by our laboratory experiments. The human CASP1 gene, located at chromosome 11q22, encodes the inflammatory protease caspase-1 (Zhen et al., 2024; Sollberger et al., 2014). Unlike apoptotic caspases, caspase-1 uses its N-terminal CARD domain to assemble into the inflammasome (He et al., 2016). Caspase-1 has been proposed as a sensitive biomarker for ocular surface damage (Tovar et al., 2022). Evidence has positioned the NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway as a significant contributor to ocular surface dysfunction. Hyperosmotic stress upregulates caspase-1 activity, driving HCEC pyroptosis and compromising the corneal epithelial barrier (Li et al., 2022). Targeting this axis has been shown to alleviate corneal epithelial injury in models induced by benzalkonium chloride (BAC) or hyperosmotic stress (Lou et al., 2023; Zhang J. et al., 2021). In the BAC-induced model, the accumulation of reactive oxygen species (ROS) and subsequent oxidation of mitochondrial DNA (mt-DNA) appear to be the triggers for NLRP3 inflammasome activation (Lou et al., 2023). Moreover, caspase-1-dependent pyroptosis contributes to the pathogenesis of meibomian gland dysfunction (Wu et al., 2025). ROS accumulation serves as a classic upstream trigger for inflammasome assembly (Pandey et al., 2025). Activation of the inflammasome triggers caspase-1 to cleave its downstream substrate GSDMD, leading to membrane pore formation, cytosolic leakage (pyroptosis), and the maturation of pro-inflammatory cytokines IL-1β and IL-18 (Pandey et al., 2025; Xu and Núñez, 2023; Shi et al., 2017; Yu et al., 2021). This cascade not only executes programmed cell death in corneal epithelial cells but also amplifies local inflammatory responses, directly compromising ocular surface barrier integrity and tear film stability (Zhang Y. et al., 2021). Systemic toxicological models mirror this mechanism: BPA directly induces osteocyte pyroptosis via the ROS/NLRP3/caspase-1 axis (Zhang et al., 2022), hyperactivates inflammasomes in myeloid cells (Panchanathan et al., 2015), and exacerbates liver metabolic dysfunction through oxidative crosstalk (Pirozzi et al., 2020). We hypothesized that BPA exacerbates DED by upregulating CASP1 and hyperactivating the ocular surface inflammasome-pyroptosis axis. Our qRT-PCR and Western blot analyses demonstrated that BPA exposure markedly elevated the expression of caspase-1, GSDMD, and downstream cytokines in HCECs at both the mRNA and active protein levels. The application of the caspase-1 inhibitor Ac-YVAD-CHO successfully reversed these transcriptomic alterations, mitigated ROS accumulation, and significantly reduced the protein abundances of cleaved caspase-1, mature IL-1β, and mature IL-18. Intriguingly, although the decrease in N-GSDMD protein levels did not achieve absolute statistical significance upon caspase-1 impedance, the comprehensive attenuation of downstream mature cytokines and the robust rescue of cell survival strongly validate that blocking this molecular junction remains functionally effective. These validations confirm that BPA mediates cellular pyroptosis and exacerbates ocular surface inflammation through the activation of the CASP1/GSDMD axis.

GSEA revealed a strong correlation between elevated CASP1 expression and enhanced mitochondrial oxidative phosphorylation (OXPHOS) alongside increased ribosomal function. Upregulated OXPHOS exacerbates electron transport chain leakage, generating a continuous ROS supply that serves as a persistent trigger for NLRP3 inflammasome assembly (Kelley et al., 2019). Heightened ribosomal activity supplies the essential biosynthetic foundation for translating pro-inflammatory mediators. Such metabolic vigorousness is highly consistent with the energetic requirements of caspase-1 as an inflammatory effector enzyme. A corresponding negative enrichment in transcriptional regulation pathways confirms this cellular transition toward the execution of inflammation.

When evaluating immune infiltration, we observed a positive correlation between CASP1 expression levels and M0 macrophage abundance in the aggregated data. However, stratifying the samples by disease status significantly attenuated this association, demonstrating Simpson’s paradox, a statistical phenomenon where a global trend disappears within specific subgroups (Ameringer et al., 2009). This statistical discrepancy confirms that the observed association is primarily driven by the overall disease status rather than direct regulatory relationships. Within the ocular surface microenvironment, CASP1 primarily functions as an intracellular inflammatory effector that processes downstream cytokines rather than a direct driver of immune cell recruitment. Toxicology studies must assess functional cellular activation states rather than relying solely on simple cell counts.

Overall, the present study integrates in silico toxicological predictions, Mendelian randomization, and in vitro validation to explore the BPA-DED axis. Despite multiple lines of evidence, objective limitations remain. The screening strategy relied on intersecting predicted targets of BPA with differentially expressed genes from corneal tissues of patients with DED. These altered genes may reflect the consequences of advanced disease stages. Therefore, this approach cannot fully differentiate between biological causes and consequences. Future validation requires the use of tissue specific data or transcriptomic profiles obtained under direct exposure to BPA. The integration of transcriptomic datasets with small sample sizes represents another limitation. Although the batch correction protocol successfully aligned the mean expression vectors, variance differences remained. The concentration ellipses exhibited distinct orientations, which reflects the statistical instability of small sample groups containing only four or five replicates. This variance heterogeneity represents study specific characteristics that persist after mean adjustment, which may introduce a selection bias during the initial differential gene screening. Future investigations using larger datasets are required to minimize these selection biases. The instrumental variables for CASP1 expression were derived from whole blood eQTL data due to the lack of ocular tissue specific databases. Although blood serves as a proxy for systemic inflammatory pathways, this choice introduces a potential tissue specific bias. Future validation requires corneal tissue specific genetic association datasets to confirm these local regulatory effects. Another limitation involves the high concentration of BPA used for our cellular validation. The concentration of 100 μM is higher than typical human environmental exposure levels. The primary purpose of this study is not to represent daily human contact, but rather to discover and characterize the downstream pathological processes and molecular mechanisms driven by BPA exposure. Specifically, micromolar concentrations of BPA have been shown to induce DNA damage and apoptosis in human epithelial cells (George and Rupasinghe, 2018), activate the ROS and caspase 1 pyroptotic axis in immune cell models (Xu et al., 2024b), and trigger robust para inflammatory responses in in vitro epithelial models (Loffredo et al., 2020). However, these acute parameters do not completely represent the chronic accumulation patterns found in real world settings. Future investigations must include experiments using lower concentrations over longer exposure periods to better simulate human environmental conditions. A single cell line model cannot emulate the complex microenvironment of the ocular surface, missing the interactions among the corneal epithelium, conjunctival goblet cells, and immune populations. Future research requires confirmation in animal models and clinical samples to validate these mechanisms. Additional laboratory studies are also necessary to strengthen our observations. These investigations should include the assessment of genetic knockdown using small interfering RNA and the evaluation of alternative specific inhibitors. Developing topical ophthalmic formulations that block the CASP1/GSDMD axis offers a strategy for managing DED.

5. Conclusion

This study identifies CASP1 as the central molecular hub linking BPA exposure to DED. BPA exposure impairs HCEC viability and triggers membrane damage alongside a surge in intracellular ROS. BPA promotes ocular surface injury by activating the CASP1/GSDMD-mediated pyroptotic axis and its associated inflammatory cascade. Inhibition of CASP1 effectively abrogates this process, suggesting potential avenues for clinical intervention.

Acknowledgments

We would like to acknowledge the contributions of all team members who participated in this study.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. This research was supported by the Natural Science Foundation of Shandong Province (ZR2024MH217).

Edited by: Alla P. Toropova, Mario Negri Institute for Pharmacological Research (IRCCS), Italy

Reviewed by: Lusheng Wang, Wenzhou Medical University, China

Yaojun Wang, Hebei University, China

Abbreviations: BPA, Bisphenol A; DED, Dry Eye Disease; HCECs, Human Immortalized Corneal Epithelial Cells; MR, Mendelian Randomization; IVW, Inverse Variance Weighted; SNP, Single Nucleotide Polymorphism; GWAS, Genome-Wide Association Study; eQTL, expression Quantitative Trait Loci; GEO, Gene Expression Omnibus; DEG, Differentially Expressed Gene; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, Gene Set Enrichment Analysis; NES, Normalized Enrichment Score; FDR, False Discovery Rate; PPI, Protein-Protein Interaction; LASSO, Least Absolute Shrinkage and Selection Operator; SVM-RFE, Support Vector Machine-Recursive Feature Elimination; MCC, Maximum Neighborhood Component; ROS, Reactive Oxygen Species; LDH, Lactate Dehydrogenase; CCK-8, Cell Counting Kit-8; RT-qPCR, Quantitative Real-Time Polymerase Chain Reaction; BBB, Blood-Brain Barrier.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.

Author contributions

YW: Writing – review and editing, Validation, Methodology, Writing – original draft, Data curation. CJ: Data curation, Writing – original draft, Formal Analysis. YZ: Data curation, Writing – original draft. KL: Writing – original draft, Software, Investigation. KL: Project administration, Writing – review and editing. YW: Methodology, Writing – original draft. MX: Writing – original draft, Visualization, Data curation. QW: Investigation, Funding acquisition, Writing – review and editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2026.1880522/full#supplementary-material

Image1.tif (1.8MB, tif)

References

  1. Acconcia F., Pallottini V., Marino M. (2015). Molecular mechanisms of action of BPA. Dose-Response 13 (4), 1559325815610582. 10.1177/1559325815610582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adamovsky O., Groh K. J., Białk-Bielińska A., Escher B. I., Beaudouin R., Mora Lagares L., et al. (2024). Exploring BPA alternatives - environmental levels and toxicity review. Environ. International 189, 108728. 10.1016/j.envint.2024.108728 [DOI] [PubMed] [Google Scholar]
  3. Alves M., Asbell P., Dogru M., Giannaccare G., Grau A., Gregory D., et al. (2023). TFOS lifestyle report: impact of environmental conditions on the ocular surface. Ocular Surface 29, 1–52. 10.1016/j.jtos.2023.04.007 [DOI] [PubMed] [Google Scholar]
  4. Ameringer S., Serlin R. C., Ward S. (2009). Simpson's paradox and experimental research. Nurs. Res. 58 (2), 123–127. 10.1097/NNR.0b013e318199b517 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baratta R. O., Schlumpf E., Buono B. J. D., DeLorey S., Calkins D. J. (2022). Corneal collagen as a potential therapeutic target in dry eye disease. Surv. Ophthalmol. 67 (1), 60–67. 10.1016/j.survophthal.2021.04.006 [DOI] [PubMed] [Google Scholar]
  6. Britten-Jones A. C., Wang M. T. M., Samuels I., Jennings C., Stapleton F., Craig J. P. (2024). Epidemiology and risk factors of dry eye disease: considerations for clinical management. Med. Kaunas. Lith. 60 (9), 1458. 10.3390/medicina60091458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Celar Sturm D., Virant-Klun I. (2023). Negative effects of endocrine disruptor bisphenol A on ovarian granulosa cells and the protective role of folic acid. Reprod. Camb. Engl. 165 (5), R117–R134. 10.1530/REP-22-0257 [DOI] [PubMed] [Google Scholar]
  8. Chen J., Ran B., Chen B., Bai J., Jian S., Huang Y., et al. (2025). Toxicological impacts and mechanistic insights of bisphenol a on clear cell renal cell carcinoma progression: a network toxicology, machine learning and molecular docking study. Biomedicines 13 (11), 2778. 10.3390/biomedicines13112778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chen T., Chen H., Cheng Y., Chen J., Lin S., Liu L., et al. (2025). Integrated network toxicology and experimental validation reveal the mechanism of bisphenol A-Induced kidney injury: targeting macrophage Esr1 expression and apoptosis. J. Biochemical Molecular Toxicology 39 (7), e70348. 10.1002/jbt.70348 [DOI] [PubMed] [Google Scholar]
  10. Chi K., Yang S., Zhang Y., Zhao Y., Zhao J., Chen Q., et al. (2024). Exploring the mechanism of tingli pill in the treatment of HFpEF based on network pharmacology and molecular docking. Medicine 103 (16), e37727. 10.1097/MD.0000000000037727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chu L., Wang C., Zhou H. (2024). Inflammation mechanism and anti-inflammatory therapy of dry eye. Front. Medicine 11, 1307682. 10.3389/fmed.2024.1307682 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clayton J. A. (2018). Dry eye. N. Engl. Journal Medicine 378 (23), 2212–2223. 10.1056/NEJMra1407936 [DOI] [PubMed] [Google Scholar]
  13. Costa H. E., Cairrao E. (2024). Effect of bisphenol A on the neurological system: a review update. Archives Toxicology 98 (1), 1–73. 10.1007/s00204-023-03614-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dong Y., Gao L., Sun Q., Jia L., Liu D. (2023). Increased levels of IL-17 and autoantibodies following bisphenol A exposure were associated with activation of PI3K/AKT/mTOR pathway and abnormal autophagy in MRL/Lpr mice. Ecotoxicol. Environmental Safety 255, 114788. 10.1016/j.ecoenv.2023.114788 [DOI] [PubMed] [Google Scholar]
  15. Garbutcheon-Singh K. B., Carnt N., Pattamatta U., Samarawickrama C., White A., Calder V. (2019). A review of the cytokine IL-17 in ocular surface and corneal disease. Curr. Eye Res. 44 (1), 1–10. 10.1080/02713683.2018.1519834 [DOI] [PubMed] [Google Scholar]
  16. George V. C., Rupasinghe H. P. V. (2018). DNA damaging and apoptotic potentials of bisphenol A and bisphenol S in human bronchial epithelial cells. Environ. Toxicology Pharmacology 60, 52–57. 10.1016/j.etap.2018.04.009 [DOI] [PubMed] [Google Scholar]
  17. Guimarães A. G. C., Coutinho V. L., Meyer A., Lisboa P. C., de Moura E. G. (2023). Human exposure to bisphenol A (BPA) through medical-hospital devices: a systematic review. Environ. Toxicology Pharmacology 97, 104040. 10.1016/j.etap.2022.104040 [DOI] [PubMed] [Google Scholar]
  18. Han R., Gao J., Wang L., Hao P., Chen X., Wang Y., et al. (2023). MicroRNA-146a negatively regulates inflammation via the IRAK1/TRAF6/NF-κB signaling pathway in dry eye. Sci. Reports 13 (1), 11192. 10.1038/s41598-023-38367-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harley K. G., Aguilar Schall R., Chevrier J., Tyler K., Aguirre H., Bradman A., et al. (2013). Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ. Health Perspectives 121 (4), 514–520. 10.1289/ehp.1205548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. He Y., Hara H., Núñez G. (2016). Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem. Sci. 41 (12), 1012–1021. 10.1016/j.tibs.2016.09.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hong X., Zhou Y., Zhu Z., Li Y., Li Z., Zhang Y., et al. (2023). Environmental endocrine disruptor bisphenol A induces metabolic derailment and obesity via upregulating IL-17A in adipocytes. Environ. International 172, 107759. 10.1016/j.envint.2023.107759 [DOI] [PubMed] [Google Scholar]
  22. Hong Y., Wang D., Lin Y., Yang Q., Wang Y., Xie Y., et al. (2024). Environmental triggers and future risk of developing autoimmune diseases: molecular mechanism and network toxicology analysis of bisphenol A. Ecotoxicol. Environmental Safety 288, 117352. 10.1016/j.ecoenv.2024.117352 [DOI] [PubMed] [Google Scholar]
  23. Huang R. G., Li X. B., Wang Y. Y., Wu H., Li K. D., Jin X., et al. (2023). Endocrine-disrupting chemicals and autoimmune diseases. Environ. Research 231 (Pt 2), 116222. 10.1016/j.envres.2023.116222 [DOI] [PubMed] [Google Scholar]
  24. Hyun S. A., Ka M. (2024). Bisphenol A (BPA) and neurological disorders: an overview. International Journal Biochemistry and Cell Biology 173, 106614. 10.1016/j.biocel.2024.106614 [DOI] [PubMed] [Google Scholar]
  25. Ighalo J. O., Kurniawan S. B., Khongthaw B., Buhari J., Chauhan P. K., Georgin J., et al. (2024). Bisphenol A (BPA) toxicity assessment and insights into current remediation strategies. RSC Advances 14 (47), 35128–35162. 10.1039/d4ra05628k [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Karthikeyan B. S., Ravichandran J., Mohanraj K., Vivek-Ananth R. P., Samal A. (2019). A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations. Sci. Total Environment 692, 281–296. 10.1016/j.scitotenv.2019.07.225 [DOI] [PubMed] [Google Scholar]
  27. Kelley N., Jeltema D., Duan Y., He Y. (2019). The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 20 (13), 3328. 10.3390/ijms2013328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kim J., Kim J. G., Li Y., You S., Lee N., Kim W. U. (2025). LSP1 deficiency increases IL-17-expressing T cells and accelerates primary sjögren's syndrome. Clin. Immunology Orl. Fla 280, 110548. 10.1016/j.clim.2025.110548 [DOI] [PubMed] [Google Scholar]
  29. Le Corre L., Besnard P., Chagnon M. C. (2015). BPA, an energy balance disruptor. Crit. Rev. Food Sci. Nutr. 55 (6), 769–777. 10.1080/10408398.2012.678421 [DOI] [PubMed] [Google Scholar]
  30. Li J., Yang K., Pan X., Peng H., Hou C., Xiao J., et al. (2022). Long noncoding RNA MIAT regulates hyperosmotic stress-induced corneal epithelial cell injury via inhibiting the Caspase-1-Dependent pyroptosis and apoptosis in dry eye disease. J. Inflammation Research 15, 3269–3283. 10.2147/JIR.S361541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Li P., Gan Z., Li Z., Wang B., Sun W., Su S., et al. (2024). Occurrence and exposure evaluation of bisphenol A and its analogues in indoor and outdoor dust from China. Sci. Total Environment 920, 170833. 10.1016/j.scitotenv.2024.170833 [DOI] [PubMed] [Google Scholar]
  32. Li Y., Chen X., Zhong P., Xing Y., Miao P. (2025). Exploring the pathophysiological relationship between bisphenol A exposure and ischemic stroke risk using network toxicology and machine learning. BMC Neurology 25 (1), 439. 10.1186/s12883-025-04460-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lin C. C., Chiu C. C., Lee P. Y., Chen K. J., He C. X., Hsu S. K., et al. (2022). The adverse effects of air pollution on the eye: a review. Int. Journal Environmental Research Public Health 19 (3), 1186. 10.3390/ijerph19031186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lin C., Wu J., Jing Y., Xie J., Xiang J., Fan Q., et al. (2025). NF-κB/IL-6 axis drives impaired corneal wound healing in aqueous-deficient dry eye. Front. Immunology 16, 1684290. 10.3389/fimmu.2025.1684290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Liu Z., Lu Y., Zhong K., Wang C., Xu X. (2022). The associations between endocrine disrupting chemicals and markers of inflammation and immune responses: a systematic review and meta-analysis. Ecotoxicol. Environmental Safety 234, 113382. 10.1016/j.ecoenv.2022.113382 [DOI] [PubMed] [Google Scholar]
  36. Loffredo L. F., Coden M. E., Berdnikovs S. (2020). Endocrine disruptor bisphenol A (BPA) triggers systemic para-inflammation and is sufficient to induce airway allergic sensitization in mice. Nutrients 12 (2), 343. 10.3390/nu12020343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lou Q., Pan L., Xiang S., Li Y., Jin J., Tan J., et al. (2023). Suppression of NLRP3/Caspase-1/GSDMD mediated corneal epithelium pyroptosis using melatonin-loaded liposomes to inhibit benzalkonium chloride-induced dry eye disease. Int. Journal Nanomedicine 18, 2447–2463. 10.2147/IJN.S403337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lv Y., Rui C., Dai Y., Pang Q., Li Y., Fan R., et al. (2016). Exposure of children to BPA through dust and the association of urinary BPA and triclosan with oxidative stress in guangzhou, China. Environ. Science Process. and Impacts 18 (12), 1492–1499. 10.1039/c6em00472e [DOI] [PubMed] [Google Scholar]
  39. Ma Y., Liu H., Wu J., Yuan L., Wang Y., Du X., et al. (2019). The adverse health effects of bisphenol A and related toxicity mechanisms. Environ. Research 176, 108575. 10.1016/j.envres.2019.108575 [DOI] [PubMed] [Google Scholar]
  40. Majeed A., Mukhtar S. (2023). Protein-protein interaction network exploration using cytoscape. Methods Molecular Biology Clift. NJ 2690, 419–427. 10.1007/978-1-0716-3327-4_32 [DOI] [PubMed] [Google Scholar]
  41. Meng Y., Yannan Z., Ren L., Qi S., Wei W., Lihong J. (2020). Adverse reproductive function induced by maternal BPA exposure is associated with abnormal autophagy and activating inflamation via mTOR and TLR4/NF-κB signaling pathways in female offspring rats. Reprod. Toxicol. 96, 185–194. 10.1016/j.reprotox.2020.07.001 [DOI] [PubMed] [Google Scholar]
  42. Messmer E. M. (2015). The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch. Arzteblatt International 112 (5), 71–81. 10.3238/arztebl.2015.0071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pan Y., Xie R., Wei X., Li A. J., Zeng L. (2024). Bisphenol and analogues in indoor dust from E-waste recycling sites, neighboring residential homes, and urban residential homes: implications for human exposure. Sci. Total Environment 907, 168012. 10.1016/j.scitotenv.2023.168012 [DOI] [PubMed] [Google Scholar]
  44. Panchanathan R., Liu H., Leung Y. K., Ho S. M., Choubey D. (2015). Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells. Mol. Cell. Endocrinol. 415, 45–55. 10.1016/j.mce.2015.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pandey A., Li Z., Gautam M., Ghosh A., Man S. M. (2025). Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis. Immunol. Rev. 329 (1), e13406. 10.1111/imr.13406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Pirozzi C., Lama A., Annunziata C., Cavaliere G., Ruiz-Fernandez C., Monnolo A., et al. (2020). Oral bisphenol A worsens liver immune-metabolic and mitochondrial dysfunction induced by high-fat diet in adult mice: cross-talk between oxidative stress and inflammasome pathway. Antioxidants. 9 (12), 1201. 10.3390/antiox9121201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Qian L., Wei W. (2022). Identified risk factors for dry eye syndrome: a systematic review and meta-analysis. PloS One 17 (8), e0271267. 10.1371/journal.pone.0271267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Radwan M., Wielgomas B., Dziewirska E., Radwan P., Kałużny P., Klimowska A., et al. (2018). Urinary bisphenol A levels and Male fertility. Am. Journal Men's Health 12 (6), 2144–2151. 10.1177/1557988318799163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rauchman S. H., Locke B., Albert J., De Leon J., Peltier M. R., Reiss A. B. (2023). Toxic external exposure leading to ocular surface injury. Vis. Basel, Switz. 7 (2), 32. 10.3390/vision7020032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Rhee M. K., Mah F. S. (2017). Inflammation in dry eye disease: how do we break the cycle? Ophthalmology 124 (11s), S14–s19. 10.1016/j.ophtha.2017.08.029 [DOI] [PubMed] [Google Scholar]
  51. Sevastre-Berghian A. C., Casandra C., Gheban D., Olteanu D., Olanescu Vaida Voevod M. C., Rogojan L., et al. (2022). Neurotoxicity of bisphenol A and the impact of melatonin administration on oxidative stress, ERK/NF-kB signaling pathway, and behavior in rats. Neurotox. Res. 40 (6), 1882–1894. 10.1007/s12640-022-00618-z [DOI] [PubMed] [Google Scholar]
  52. Shi J., Gao W., Shao F. (2017). Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42 (4), 245–254. 10.1016/j.tibs.2016.10.004 [DOI] [PubMed] [Google Scholar]
  53. Sollberger G., Strittmatter G. E., Garstkiewicz M., Sand J., Beer H. D. (2014). Caspase-1: the inflammasome and beyond. Innate Immun. 20 (2), 115–125. 10.1177/1753425913484374 [DOI] [PubMed] [Google Scholar]
  54. Stapleton F., Argüeso P., Asbell P., Azar D., Bosworth C., Chen W., et al. (2025). TFOS DEWS III: digest. Am. Journal Ophthalmol. 279, 451–553. 10.1016/j.ajo.2025.05.040 [DOI] [PubMed] [Google Scholar]
  55. Sturla S. J., Boobis A. R., FitzGerald R. E., Hoeng J., Kavlock R. J., Schirmer K., et al. (2014). Systems toxicology: from basic research to risk assessment. Chem. Research Toxicol. 27 (3), 314–329. 10.1021/tx400410s [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Szklarczyk D., Kirsch R., Koutrouli M., Nastou K., Mehryary F., Hachilif R., et al. (2023). The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638–D646. 10.1093/nar/gkac1000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Torricelli A. A., Matsuda M., Novaes P., Braga A. L., Saldiva P. H., Alves M. R., et al. (2014). Effects of ambient levels of traffic-derived air pollution on the ocular surface: analysis of symptoms, conjunctival goblet cell count and mucin 5AC gene expression. Environ. Research 131, 59–63. 10.1016/j.envres.2014.02.014 [DOI] [PubMed] [Google Scholar]
  58. Tovar A., Gomez A., Serrano A., Blanco M. P., Galor A., Swaminathan S. S., et al. (2022). Role of Caspase-1 as a biomarker of ocular surface damage. Am. J. Ophthalmology 239, 74–83. 10.1016/j.ajo.2022.01.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Tuzimski T., Szubartowski S. (2019). Method development for selected bisphenols analysis in sweetened condensed milk from a can and breast milk samples by HPLC-DAD and HPLC-QqQ-MS: comparison of sorbents (Z-SEP, Z-SEP plus, PSA, C18, chitin and EMR-Lipid) for Clean-Up of QuEChERS extract. Molecules 24 (11), 2093. 10.3390/molecules24112093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wang K., Huang D., Zhou P., Su X., Yang R., Shao C., et al. (2022). Individual and combined effect of bisphenol A and bisphenol AF on prostate cell proliferation through NF-κB signaling pathway. Int. J. Molecular Sciences 23 (20), 12283. 10.3390/ijms232012283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wang X., Ma J., Li W., Hou Z., Li H., Li Y., et al. (2025). BPA exacerbates zinc deficiency-induced testicular tissue inflammation in Male mice through the TNF-α/NF-κB/Caspase8 signaling pathway. Biol. Trace Element Research 203 (8), 4153–4163. 10.1007/s12011-024-04464-2 [DOI] [PubMed] [Google Scholar]
  62. Wu M., He H. L., Wang C., Wang B., Li Y. Z., Zhou S. R., et al. (2025). Maresin 1 ameliorates blue light overexposure-induced Meibomian gland dysfunction via inhibition of NLRP3/Caspase-1/GSDMD-Mediated pyroptosis. Investigative Ophthalmol. Visual Science 66 (13), 29. 10.1167/iovs.66.13.29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Xing J., Zhang S., Zhang M., Hou J. (2022). A critical review of presence, removal and potential impacts of endocrine disruptors bisphenol A. Comparative biochemistry and physiology toxicology and pharmacology. CBP 254, 109275. [DOI] [PubMed] [Google Scholar]
  64. Xu J., Núñez G. (2023). The NLRP3 inflammasome: activation and regulation. Trends Biochem. Sci. 48 (4), 331–344. 10.1016/j.tibs.2022.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Xu T., Zhang Y., Liu H., Shi X., Liu Y. (2024a). BPA exposure and Se deficiency caused spleen damage in chickens by nitrification stress-TNF-α. J. Environ. Manage 367, 121994. 10.1016/j.jenvman.2024.121994 [DOI] [PubMed] [Google Scholar]
  66. Xu T., Chen T., Shi X., Ding J., Chen S., Lin H. (2024b). Co-exposure of bisphenol A and selenium deficiency induces pyroptosis via ROS/NLRP3 pathway in chicken spleen. Poult. Sci. 103 (10), 104150. 10.1016/j.psj.2024.104150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Yang Q., Li K., Li D., Zhang Y., Liu X., Wu K. (2019). Effects of fine particulate matter on the ocular surface: an in vitro and in vivo study. Biomed. Pharmacotherapy 117, 109177. 10.1016/j.biopha.2019.109177 [DOI] [PubMed] [Google Scholar]
  68. Yu P., Zhang X., Liu N., Tang L., Peng C., Chen X. (2021). Pyroptosis: mechanisms and diseases. Signal Transduction Targeted Therapy 6 (1), 128. 10.1038/s41392-021-00507-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Zemanová M. (2021). DRY EYE DISEASE. A REVIEW. Ceska a Slovenska Oftalmol. 77 (3), 107–119. 10.31348/2020/29 [DOI] [PubMed] [Google Scholar]
  70. Zhang W., Chen Y., Jiang H., Yang J., Wang Q., Du Y., et al. (2020). Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology. Talanta. 211, 120710. 10.1016/j.talanta.2020.120710 [DOI] [PubMed] [Google Scholar]
  71. Zhang J., Dai Y., Yang Y., Xu J. (2021). Calcitriol alleviates hyperosmotic stress-induced corneal epithelial cell damage via inhibiting the NLRP3-ASC-Caspase-1-GSDMD pyroptosis pathway in dry eye disease. J. Inflammation Research 14, 2955–2962. 10.2147/JIR.S310116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Zhang Y., Jiao Y., Li X., Gao S., Zhou N., Duan J., et al. (2021). Pyroptosis: a new insight into eye disease therapy. Front. Pharmacol. 12, 797110. 10.3389/fphar.2021.797110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Zhang Y., Yan M., Shan W., Zhang T., Shen Y., Zhu R., et al. (2022). Bisphenol A induces pyroptotic cell death via ROS/NLRP3/Caspase-1 pathway in osteocytes MLO-Y4. Food Chemical Toxicology An International Journal Published Br. Industrial Biol. Res. Assoc. 159, 112772. 10.1016/j.fct.2021.112772 [DOI] [PubMed] [Google Scholar]
  74. Zhen H., Hu Y., Liu X., Fan G., Zhao S. (2024). The protease caspase-1: activation pathways and functions. Biochem. Biophys. Res. Commun. 717, 149978. 10.1016/j.bbrc.2024.149978 [DOI] [PubMed] [Google Scholar]
  75. Zhu L., Hajeb P., Fauser P., Vorkamp K. (2023). Endocrine disrupting chemicals in indoor dust: a review of temporal and spatial trends, and human exposure. Sci. Total Environment 874, 162374. 10.1016/j.scitotenv.2023.162374 [DOI] [PubMed] [Google Scholar]
  76. Zhu D., Wu X. Y., Li L. C. (2025). Obtusifolin ameliorates dry eye model in rats by reducing inflammation and blocking MAPK/NF-κB pathways. Int. Journal Ophthalmology 18 (8), 1426–1432. 10.18240/ijo.2025.08.02 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Image1.tif (1.8MB, tif)

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES